Accutar Biotechnology Inc. — Form D

Accutar Biotechnology Inc. of Brooklyn, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-05. The offering totals $28.5M, of which $28.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-01-05
• Form: D
• Accession: 0001783798-21-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $28.5M
• Amount sold: $28.5M
• Investors: 5
• Date of first sale: 2020-12-04
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-385251

Issuer

• Name: Accutar Biotechnology Inc.
• CIK: 0001783798
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2015
• Address: 760 Parkside Avenue, Suite 213, Brooklyn, NY, 11226
• Phone: 646-462-5083

Officers, directors & promoters (9)

Other filings by this issuer (2)

More

• CIK 1783798 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search